Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 776.82%1.73M | 83.25%424.16K | 95.21%396.79K | -59.68%1.15M | -0.15%520.57K | -47.29%197.22K | -74.54%231.46K | -80.71%203.26K | -21.51%2.86M | -48.35%521.33K |
| Selling and administrative expenses | 820.43%1.59M | 91.24%410.23K | 84.32%392.95K | -54.36%1.12M | 8.26%521.12K | -50.58%173.04K | -73.21%214.52K | -74.19%213.2K | -18.92%2.46M | -47.19%481.34K |
| -Selling and marketing expense | --0 | --0 | --0 | -97.62%6.69K | -99.89%234 | --0 | --0 | -85.84%6.45K | -43.39%280.61K | 56.34%204.75K |
| -General and administrative expense | 820.43%1.59M | 91.24%410.23K | 90.07%392.95K | -48.78%1.12M | 88.32%520.88K | -47.89%173.04K | -72.79%214.52K | -73.51%206.74K | -14.14%2.18M | -64.57%276.59K |
| Research and development costs | --0 | --0 | --0 | -106.98%-17.72K | -107.41%-2.27K | 62.62%-616 | -85.56%9.37K | -115.13%-24.21K | -52.48%253.78K | -52.50%30.58K |
| Depreciation amortization depletion | -92.57%157 | -94.98%157 | -94.98%157 | -31.29%8.52K | -94.98%157 | -32.46%2.11K | 0.00%3.13K | 3.47%3.13K | 11.60%12.4K | 5.29%3.13K |
| -Depreciation and amortization | -92.57%157 | -94.98%157 | -94.98%157 | -31.29%8.52K | -94.98%157 | -32.46%2.11K | 0.00%3.13K | 3.47%3.13K | 11.60%12.4K | 5.29%3.13K |
| Other operating expenses | 501.21%136.37K | 209.30%13.77K | -67.03%3.68K | -70.30%39.84K | -75.16%1.56K | 0.70%22.68K | -88.97%4.45K | -82.84%11.15K | 106.64%134.14K | -79.43%6.28K |
| Operating profit | -776.82%-1.73M | -83.25%-424.16K | -95.21%-396.79K | 59.68%-1.15M | 0.15%-520.57K | 47.29%-197.22K | 74.54%-231.46K | 80.71%-203.26K | 21.51%-2.86M | 48.35%-521.33K |
| Net non-operating interest income (expenses) | 0 | 94.97%-671 | 0 | -60.59%-66.89K | -77.38%-33.36K | 96.02%-461 | -49.13%-13.35K | -757.81%-19.72K | -3,744.27%-41.65K | -5,124.17%-18.81K |
| Non-operating interest income | --0 | --0 | --0 | -91.40%205 | -90.67%54 | -95.58%25 | -88.59%63 | -90.83%63 | -2.89%2.38K | 2.84%579 |
| Non-operating interest expense | --0 | -95.00%671 | --0 | 52.37%67.1K | 72.36%33.41K | -96.00%486 | 41.13%13.42K | 562.56%19.78K | 3,259.04%44.04K | 2,000.33%19.39K |
| Other net income (expenses) | -33.4K | 101.21%27.85K | -190.74%-3.84K | -3,443.15%-2.58M | -2,188.32%-291.44K | -5,177.48%-2.3M | 308.26%4.23K | 99.13%-72.94K | 99.85%-12.74K | |
| Gain on sale of security | ---33.4K | 260.89%27.85K | -190.74%-3.84K | -14.14%-32.37K | -50.18%-19.3K | ---- | -137.12%-17.31K | 308.26%4.23K | -479.69%-28.36K | -309.22%-12.85K |
| Special income (charges) | --0 | --0 | ---- | -5,624.83%-2.55M | -243,087.50%-272.15K | --0 | -6,193.26%-2.28M | ---- | 99.47%-44.58K | 100.00%112 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | 6,913.51%2.55M | --272.15K | ---- | --2.28M | ---- | ---37.46K | ---- |
| -Less:Write off | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | --82.04K | --37.34K |
| Income before tax | -791.67%-1.76M | 84.38%-396.98K | -83.15%-400.63K | -27.95%-3.8M | -52.90%-845.37K | 50.63%-197.68K | -164.40%-2.54M | 79.33%-218.75K | 75.21%-2.97M | 94.10%-552.87K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -791.67%-1.76M | 84.38%-396.98K | -83.15%-400.63K | -27.95%-3.8M | -52.90%-845.37K | 50.63%-197.68K | -164.40%-2.54M | 79.33%-218.75K | 75.21%-2.97M | 94.10%-552.87K |
| Net income continuous operations | -791.67%-1.76M | 84.38%-396.98K | -83.15%-400.63K | -27.95%-3.8M | -52.90%-845.37K | 50.63%-197.68K | -164.40%-2.54M | 79.33%-218.75K | 75.21%-2.97M | 94.10%-552.87K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -791.67%-1.76M | 84.38%-396.98K | -83.15%-400.63K | -27.95%-3.8M | -52.90%-845.37K | 50.63%-197.68K | -164.40%-2.54M | 79.33%-218.75K | 75.21%-2.97M | 94.10%-552.87K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -791.67%-1.76M | 84.38%-396.98K | -83.15%-400.63K | -27.95%-3.8M | -52.90%-845.37K | 50.63%-197.68K | -164.40%-2.54M | 79.33%-218.75K | 75.21%-2.97M | 94.10%-552.87K |
| Diluted earnings per share | -266.67%-0.11 | 97.52%-0.03 | 40.00%-0.06 | 44.97%-0.82 | 43.04%-0.15 | 97.00%-0.03 | -2,320.00%-1.21 | 81.82%-0.1 | 98.64%-1.49 | 94.69%-0.2634 |
| Basic earnings per share | -266.67%-0.11 | 97.52%-0.03 | 40.00%-0.06 | 44.97%-0.82 | 43.04%-0.15 | 97.00%-0.03 | -2,320.00%-1.21 | 81.82%-0.1 | 98.64%-1.49 | 94.69%-0.2634 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.